168 related articles for article (PubMed ID: 22371290)
21. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
22. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
23. Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis.
Bernstein RM; Hobbs RN; Lea DJ; Ward DJ; Hughes GR
Arthritis Rheum; 1985 Mar; 28(3):285-93. PubMed ID: 3872129
[TBL] [Abstract][Full Text] [Related]
24. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
Levo Y; Lotan C
Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
[No Abstract] [Full Text] [Related]
25. SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes.
Neugebauer KM; Merrill JT; Wener MH; Lahita RG; Roth MB
Arthritis Rheum; 2000 Aug; 43(8):1768-78. PubMed ID: 10943867
[TBL] [Abstract][Full Text] [Related]
26. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
27. The role of antibodies directed against double-stranded DNA in the manifestations of systemic lupus erythematosus in childhood.
Lehman TJ; Hanson V; Singsen BH; Kornreich HK; Bernstein B; King K
J Pediatr; 1980 Apr; 96(4):657-61. PubMed ID: 6965717
[TBL] [Abstract][Full Text] [Related]
28. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
[TBL] [Abstract][Full Text] [Related]
29. Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus.
Muller S; Briand JP; Van Regenmortel MH
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8176-80. PubMed ID: 2847153
[TBL] [Abstract][Full Text] [Related]
30. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
31. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
32. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
33. Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.
Touloupi E; Routsias JG; Tzioufas AG
Clin Exp Immunol; 2005 Oct; 142(1):172-9. PubMed ID: 16178873
[TBL] [Abstract][Full Text] [Related]
34. Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay.
Bayer PM; Bauerfeind S; Bienvenu J; Fabien N; Frei PC; Gilburd B; Heide KG; Hoier-Madsen M; Meroni PL; Monier JC; Monneret G; Panzeri P; Shoenfeld Y; Spertini F; Wiik A
J Autoimmun; 1999 Aug; 13(1):89-93. PubMed ID: 10441172
[TBL] [Abstract][Full Text] [Related]
35. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjögren's syndrome, rheumatoid arthritis or inflammatory bowel disease.
Sjöwall C; Eriksson P; Almer S; Skogh T
J Autoimmun; 2002 Nov; 19(3):155-60. PubMed ID: 12419286
[TBL] [Abstract][Full Text] [Related]
37. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
38. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
39. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
40. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
